Categories: Coronavirus

World Bank approved $12 bln for coronavirus vaccines and tests

The FINANCIAL — The World Bank’s Board of Executive Directors approved an envelope of $12 billion for developing countries to finance the purchase and distribution of COVID-19 vaccines, tests, and treatments for their citizens. 

The financing, which aims to support vaccination of up to a billion people, is part of an overall World Bank Group (WBG) package of up to $160 billion through June 2021 to help developing countries fight the COVID-19 pandemic. It adds new financing to the World Bank’s COVID-19 emergency response programs that are already reaching 111 countries. This financing package helps signal to the research and pharmaceutical industry that citizens in developing countries also need access to safe and effective COVID-19 vaccines.  It will also provide financing and technical support so that developing countries can prepare for deploying vaccines at scale, in coordination with international partners. In implementing the program, the World Bank will support multilateral efforts currently led by WHO and COVAX.

“We are extending and expanding our fast-track approach to address the COVID emergency so that developing countries have fair and equal access to vaccines,” said World Bank Group President David Malpass. “Access to safe and effective vaccines and strengthened delivery systems is key to alter the course of the pandemic and help countries experiencing catastrophic economic and fiscal impacts move toward a resilient recovery.”

ADVERTISEMENT

Developing countries will have different ways to acquire and deliver approved vaccines. The approach draws on the WBG’s significant expertise in supporting large scale immunization programs for vaccine preventable diseases, as well as public health programs to tackle infectious diseases such as HIV, tuberculosis, malaria and neglected tropical diseases.

In addition to purchasing COVID-19 vaccines, the WBG financing will also support countries to access to COVID-19 tests and treatments, and expand immunization capacity to help health systems deploy the vaccines effectively.  This includes supply chain and logistics management for vaccine storage handling, trained vaccinators, and large-scale communication and outreach campaigns to reach communities and households.

The new financing builds on the broader World Bank health program, which focuses on strengthening the health systems and health service delivery. The Bank’s robust network of technical advice and implementation support capacity, already working on the ground in many developing countries with partner agencies, will help to further strengthen these systems.

The International Finance Corporation (IFC), the WBG’s private sector arm, is also investing in vaccine manufacturers through its $4 billion Global Health Platform. The aim is to encourage ramped-up production of COVID-19 vaccines and therapeutics in advanced and developing economies alike—and to ensure that emerging markets gain access to available doses.

The FINANCIAL

Recent Posts

Bank of America Study Finds 84% of Employers Now Say Offering Financial Wellness Tools Helps Increase Employee Retention

The FINANCIAL -- 97% of employers feel responsible for employee financial wellness, with 91% seeing…

17 mins ago

How Global South cities can work better: free course based on Oxford-led urban research

A new, free course ‘Shaping Urban Futures’, aimed at planners, policymakers and people with an…

30 mins ago

Discovery of new nanowire assembly process could enable more powerful computer chips

Researchers from Oxford University’s Department of Materials have developed a technique to precisely manipulate and…

37 mins ago

Face to face with ancient Egyptians

Realistic mummy portraits shed light on life, death in multicultural Roman era 2,000 years ago. Realistic…

1 hour ago

What makes us human? It’s all in the hips

New study shows how pelvis evolved for walking upright, allowing birth of offspring with larger…

1 hour ago

Genetic tests set to reduce burden of joint replacement surgery

A range of ground-breaking genetic tests could help predict whether joint replacements succeed or fail. These…

2 hours ago